Trends in Psychiatry and Psychotherapy
https://trends.org.br/article/doi/10.1590/2237-6089-2016-0081
Trends in Psychiatry and Psychotherapy
Original Article

Anxiety and depression symptoms in Brazilian sexual minority ecstasy and LSD users

Sintomas de ansiedade e depressão em brasileiros não heterossexuais usuários de ecstasy e LSD

Lysa S. Remy; Juliana Scherer; Luciano Guimarães; Hilary L. Surratt; Steven P. Kurtz; Flavio Pechansky; Felix Kessler

Downloads: 0
Views: 301

Abstract

Abstract Background This study examined drug use patterns and psychiatric symptoms of anxiety and depression among young Brazilian sexual minority ecstasy and LSD users and compared findings with those reported for their heterosexual peers. Method This cross-sectional study employed targeted sampling and ethnographic mapping approaches via face-to-face interviews conducted at bars and electronic music festivals using an adapted, semi-structured version of the Global Appraisal of Individual Needs questionnaire. The sample comprised 240 male and female young adults who had used ecstasy and/or LSD in the 90 days prior to the interview and who were not on treatment for alcohol and drug abuse. Results Of the 240 subjects enrolled (mean age: 22.9±4.5 years), 28.7% were gay or bisexuals. Multivariate regression analysis showed that the prevalence of depression symptoms in the past 12 months in the sexual minority group was 37% higher than among heterosexuals (prevalence ratio [PR]=1.79; 95% confidence interval [95%CI] 1.03-3.11; p=0.037). Conclusion Strategies should be developed to assess and address individual needs and treatment approaches should be tailored to address depressive symptoms in young, sexual minority club drug users.

Keywords

Anxiety, depression, psychiatric symptoms, sexual minority, synthetic drugs

Resumo

Resumo Introdução Este estudo examinou os padrões de uso de drogas e os sintomas psiquiátricos de ansiedade e depressão entre brasileiros não heterossexuais usuários de ecstasy e/ou LSD e comparou os achados com aqueles relatados por seus pares heterossexuais. Método Este estudo transversal empregou amostragens direcionadas e abordagens de mapeamento etnográfico através de entrevistas presenciais realizadas em bares e festivais de música eletrônica usando uma versão adaptada e semiestruturada do questionário de Avaliação Global de Necessidades Individuais. A amostra incluiu 240 adultos jovens do sexo masculino e feminino que haviam usado ecstasy e/ou LSD nos 90 dias anteriores à entrevista e que não estavam em tratamento para abuso de álcool e drogas. Resultados Dos 240 sujeitos incluídos (idade média: 22,9±4,5 anos), 28,7% eram homossexuais ou bissexuais. A análise de regressão multivariada mostrou que a prevalência de sintomas de depressão nos últimos 12 meses no grupo não heterossexual foi 37% superior à dos heterossexuais [razão de prevalência (RP) = 1,79; intervalo de confiança de 95% (IC95%) 1.03-3.11; p=0,037]. Conclusão Estratégias devem ser desenvolvidas para avaliar e abordar as necessidades individuais, e as abordagens de tratamento devem ser adaptadas para sintomas depressivos em usuários de drogas jovens e não heterossexuais.

Palavras-chave

Ansiedade, depressão, sintomas psiquiátricos, não heterossexuais, drogas sintéticas

References

Cochran SD, Mays VM, Sullivan JG. Prevalence of mental disorders, psychological distress, and mental health services use among lesbian, gay, and bisexual adults in the United States. J Consult Clin Psychol. 2003;71:53-61.

Busseri MA, Willoughby T, Chalmers H, Bogaert AF. On the association between sexual attraction and adolescent risk behavior involvement: Examining mediation and moderation. Dev Psychol. 2008;44:69-80.

Conron KJ, Mimiaga MJ, Landers SJ. A population-based study of sexual orientation identity and gender differences in adult health. Am J Public Health. 2010;100:1953-60.

Cochran SD, Mays VM. Burden of psychiatric morbidity among lesbian, gay, and bisexual individuals in the California Quality of Life Survey. J Abnorm Psychol. 2009;118:647-58.

Lipsky S, Krupski A, Roy-Byrne P, Huber A, Lucenko BA, Mancuso D. Impact of sexual orientation and co-occurring disorders on chemical dependency treatment outcomes. J Stud Alcohol Drugs. 2012;73:401-12.

Austin SB, Ziyadeh N, Fisher LB, Kahn JA, Colditz GA, Frazier AL. Sexual orientation and tobacco use in a cohort study of US adolescent girls and boys. Arch Pediatr Adolesc Med. 2004;158:317-22.

Cochran SD, Mays V, Corliss H, Smith TW, Turner J. Self-reported altruistic and reciprocal behaviors among homosexually and heterosexually experienced adults: implications for HIV/AIDS service organizations. AIDS Care. 2009;21:675-82.

Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Arch Gen Psychiatry. 2004;61:807-16.

Chakraborty A, McManus S, Brugha TS, Bebbington P, King M. Mental health of the non-heterosexual population of England. Br J Psychiatry. 2011;198:143-8.

Hatzenbuehler ML, Keyes KM, Narrow WE, Grant BF, Hasin DS. Racial/ethnic disparities in service utilization for individuals with co-occurring mental health and substance use disorders in the general population: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry. 2008;69:1112-21.

Marshall BD, Socías ME, Kerr T, Zalazar V, Sued O, Arístegui I. Prevalence and correlates of lifetime suicide attempts among transgender persons in Argentina. J Homosex. 2016;63:955-67.

Cochran SD, Mays VM. Relation between psychiatric syndromes and behaviorally defined sexual orientation in a sample of the US population. Am J Epidemiol. 2000;151:516-23.

Cochran SD, Mays VM. Lifetime prevalence of suicidal symptoms and affective disorders among men reporting same-sex sexual partners: results from the NHANES III. Am J Public Health. 2000;90:573-8.

Cochran SD, Keenan C, Schober C, Mays VM. Estimates of alcohol use and clinical treatment needs among homosexually active men and women in the US population. J Consult Clin Psychol. 2000;68:1062-71.

Gilman SE, Cochran SD, Mays VM, Hughes M, Ostrow D, Kessler RC. Risk of psychiatric disorders among individuals reporting same-sex sexual partners in the National Comorbidity Survey. Am J Public Health. 2001;91:933-9.

King M, Semlyen J, Tai SS, Killaspy H, Osborn D, Popelyuk D. A systematic review of mental disorder, suicide, and deliberate self harm in lesbian, gay and bisexual people. BMC Psychiatry. 2008;8.

Warner J, McKeown E, Griffin M, Johnson K, Ramsay A, Cort C. Rates and predictors of mental illness in gay men, lesbians and bisexual men and women: results from a survey based in England and Wales. Br J Psychiatry. 2004;185:479-85.

Roxburgh A, Lea T, Wit J, Degenhardt L. Sexual identity and prevalence of alcohol and other drug use among Australians in the general population. Int J Drug Policy. 2016;28:76-82.

Cochran SD, Mays VM, Alegria M, Ortega AN, Takeuchi D. Mental health and substance use disorders among Latino and Asian American lesbian, gay, and bisexual adults. J Consult Clin Psychol. 2007;75:785-94.

Traube DE, Schrager SM, Holloway IW, Weiss G, Kipke MD. Environmental risk, social cognition, and drug use among young men who have sex with men: longitudinal effects of minority status on health processes and outcomes. Drug Alcohol Depend. 2013;127:1-7.

Ibanez GE, Kurtz SP, Surratt HL, Inciardi JA. Correlates of heterosexual anal intercourse among substance-using club-goers. Arch Sex Behav. 2010;39:959-67.

Inciardi JA, Surratt HL, Kurtz SP, Cicero TJ. Mechanisms of prescription drug diversion among drug-involved club- and street-based populations. Pain Med. 2007;8:171-83.

Barros AJ, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003;3.

Marshal MP, Dietz LJ, Friedman MS, Stall R, Smith HA, McGinley J. Suicidality and depression disparities between sexual minority and heterosexual youth: a meta-analytic review. J Adolesc Health. 2011;49:115-23.

The health of lesbian, gay, bisexual, and transgender people: building a foundation for better understanding. 2011.

Wong CF, Weiss G, Ayala G, Kipke MD. Harassment, discrimination, violence, and illicit drug use among young men who have sex with men. AIDS Educ Prev. 2010;22:286-98.

Goldberg AE, Smith JZ. Stigma, social context, and mental health: lesbian and gay couples across the transition to adoptive parenthood. J Couns Psychol. 2011;58:139-50.

Tucker JS, Ellickson PL, Klein DJ. Understanding differences in substance use among bisexual and heterosexual young women. Womens Health Issues. 2008;18:387-98.

Diaz RM, Ayala G, Bein E, Henne J, Marin BV. The impact of homophobia, poverty, and racism on the mental health of gay and bisexual Latino men: findings from 3 US cities. Am J Public Health. 2001;91:927-32.

Herek GM, Gillis JR, Ogan JC. Internalized stigma among sexual minority adults: insights from a social psychological perspective. J Couns Psychol. 2009;56:32-43.

Lea T, Reynolds R, Wit J. Alcohol and other drug use, club drug dependence and treatment seeking among lesbian, gay and bisexual young people in Sydney. Drug Alcohol Rev. 2013;32:303-11.

Carrico AW, Pollack LM, Stall RD, Shade SB, Neilands TB, Rice TM. Psychological processes and stimulant use among men who have sex with men. Drug Alcohol Depend. 2012;123:79-83.

Newcomb ME, Ryan DT, Greene GJ, Garofalo R, Mustanski B. Prevalence and patterns of smoking, alcohol use, and illicit drug use in young men who have sex with men. Drug Alcohol Depend. 2014;141:65-71.

Measham F, Moore K. Repertoires of distinction: exploring patterns of weekend polydrug use within local leisure scenes across the English night time economy. Criminol Crim Justice. 2009;9:437-64.

Measham F, Wood DM, Dargan PI, Moore K. The rise in legal highs: prevalence and patterns in the use of illegal drugs and first- and second-generation “legal highs” in South London gay dance clubs. J Subs Use. 2011;16:263-72.

Measham F, Moore K, Østergaard J. Mephedrone, “Bubble” and unidentified white powders: the contested identities of synthetic “legal highs”. Drugs Alcohol Today. 2011:137-46.

Wood DM, Measham F, Dargan PI. Our favourite drug: prevalence of use and preference for mephedrone in the London night-time economy 1 year after control. J Subs Use. 2012;68:853-6.

6169da26a9539558ac6b7a03 trends Articles
Links & Downloads

Trends Psychiatry Psychother

Share this page
Page Sections